Latest News and Press Releases

Global GLP-1 Analogues Market report, the market was valued at $54.8 billion in 2024 and is projected to reach $268.4 billion by 2030.

mRNA-3927 si inserisce strategicamente nel portafoglio delle malattie rare metaboliche di Recordati La collaborazione unisce l’expertise di Moderna nella tecnologia mRNA per i disturbi metabolicirari...

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

Beghou's 2026 Biopharma Commercialization Research Report distills key insights, challenges, and operational realities for 2026 and beyond.

Market growth is fueled by rising R&D investments, increasing trial complexity, and demand for faster, more cost-effective drug development.

Delray Beach, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Methyl Cellulose Market size is valued at USD 3.64 billion in 2025 and is expected to reach USD 5.88 billion by 2030, at a CAGR of 10.0%...

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today...

Anresco NJ Labs has expanded its laboratory network with aligned facilities on both the East and West Coasts.

First patient dosed and study open in leading oncology centers in US and AustraliaPhase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and early...